SERA Sera Prognostics, Inc.

NASDAQ

$2.04

Sera Prognostics, Inc. (SERA) is expected to report earnings on November 10, 2026, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.5% since its last earnings release on August 12, 2026.

Sera Prognostics Missed Consensus Estimates

Wednesday, August 12, 2026 · 4:05 PM ET

3rd Quarter, Sep 2026

Tuesday · 4:05 PM ET

Earnings Whisper

-

vs ($0.14)

Rev est $80K

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $2.05

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sera Prognostics, Inc.

Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care.

Sector

Healthcare

Industry

Medical Labs & Research

Charts powered in part by Lightweight Charts™ by TradingView.